Alterome Therapeutics

Alterome Therapeutics is a clinical-stage precision oncology company founded in 2021 and headquartered in San Diego, California, backed by Canaan Partners. The company designs alteration-specific cancer therapies using deep biology and chemistry expertise paired with an in-house computational chemistry platform ("The Kraken"), a custom CPU/GPU compute array for physics-based molecular simulation and drug design. Its clinical pipeline includes ALTA2618, a mutation-selective inhibitor for AKT1 E17K-driven cancers, and ALTA3263, an oral pan-KRAS ON-state inhibitor targeting more than 90% of KRAS mutations in cancer. Alterome was surfaced through the Canaan Partners portfolio and added to the API Evangelist network as a company profile; it publishes no public developer or API surface.

Alterome Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Precision Medicine.

Alterome Therapeutics’ developer surface includes engineering blog and 5 more developer resources.

🌐 Visit website 📡 Source on GitHub

12.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyPharmaceuticalsOncologyPrecision MedicineDrug DiscoveryComputational ChemistryLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 12.3/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.4 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/alterome-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 4

The organization behind the API

Website

Website

About

About

Blog

Blog

LinkedIn

Source (apis.yml)

aid: alterome-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/alterome-therapeutics.png
name: Alterome Therapeutics
description: Alterome Therapeutics is a clinical-stage precision oncology company founded in 2021 and headquartered in San
  Diego, California, backed by Canaan Partners. The company designs alteration-specific cancer therapies using deep biology
  and chemistry expertise paired with an in-house computational chemistry platform ("The Kraken"), a custom CPU/GPU compute
  array for physics-based molecular simulation and drug design. Its clinical pipeline includes ALTA2618, a mutation-selective
  inhibitor for AKT1 E17K-driven cancers, and ALTA3263, an oral pan-KRAS ON-state inhibitor targeting more than 90% of KRAS
  mutations in cancer. Alterome was surfaced through the Canaan Partners portfolio and added to the API Evangelist network
  as a company profile; it publishes no public developer or API surface.
url: https://raw.githubusercontent.com/api-evangelist/alterome-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Precision Medicine
- Drug Discovery
- Computational Chemistry
- Life Sciences
apis: []
common:
- type: Website
  url: https://www.alterome.com/
- type: About
  url: https://www.alterome.com/about/
- type: Blog
  url: https://www.alterome.com/news/
- type: TermsOfService
  url: https://www.alterome.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.alterome.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/alterome
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence